Skip to content

News

In Kazakhstan Students Debated on HIV

Over 400 students from universities of the CIS countries took part in the first international debate tournament on HIV “SpeakUp: AIDS” in Almaty, Kazakhstan. Among the debate participants, there was the best 2017 speaker in the world representing the international debate movement, the main judge Raffy Marshall (Oxford), students from the major higher educational institutions of the country as well as from the UK, Kyrgyzstan, Russia, Tajikistan, and Sweden. The international panel selected 120 teams to take part in debates on this critical social issue. The tournament was held in line with the British parliament model.

Read More

“I have HIV and it is not a verdict”

In her memories, her life is divided into ‘before’ and ‘after’ she learned she had HIV. As strange as it may seem, with the therapy ‘after’ is not a verdict, not a tragedy, not the end… We are meeting 29-year-old Amina (the name has been changed) in one of the coffee houses in Dushanbe, Tajikistan. She came to our meeting after work, short of breath, as she was afraid to be late. Good looking, with a glow of health on her cheeks, a strand of hair appearing from under her neatly tied headscarf, and snow-white teeth. One could say that she was to the full of her health. Sipping her coffee, she tells her story.

Read More

With Tuberculosis, it is Important to Take Medicine and Believe in Yourself

Sanat Alemi is one of the civil society organizations (CSOs) supported by the Improved TB/HIV prevention & care – Building models for the future project which gives support to TB patients and their relatives. Founded in 2016 in Almaty, Kazakhstan by a group of ex multidrug-resistant or extensively drug-resistant TB patients, they quickly showed successes through their established self-support groups as well as one-to-one TB patient support. Sanat Alemi is also implementing several community-based activities such as social mobilization, advocacy, and communication to improve TB literacy among people affected by TB, TB/HIV, AIDS and other socially significant diseases (drug abuse, alcoholism, etc), aiming at reducing stigma, discrimination.

Read More

AIDS 2018: Abstract Submission Guidelines

The 22nd International AIDS Conference (AIDS 2018) welcomes submission of abstracts for original contribution. Each scientific track is divided into a number of track categories. All abstract authors are asked to choose one scientific track and one track category during the submission process. We encourage work that introduces new ideas, concepts, research and deepens understanding in the field, as well as analyses of both successes and failures.

Read More

Donbass: the HIV Epidemic Growing on Both Sides of the Border

HIV is rapidly spreading in the east of Ukraine, which for over three years remains the area of military actions. For two years, pregnant women have not been tested for HIV, and medications could only be delivered illegally. The armed conflict between Russia and Ukraine divided Donbass into two parts: areas controlled by the central Ukrainian government and the so-called Donetsk and Lugansk People’s Republics (DPR and LPR). The latter are controlled by pro-Russian separatists.

Read More

The Digital Consultation from the Amsterdam Youth Force

We are glad to announce the digital consultation the Amsterdam Youth Force (AYF) is organising in the run up to 22nd International AIDS Conference (AIDS 2018.) AIDS 2018 will be an important event in the road to fulfilling the Sustainable Development Goals goal of ending the AIDS epidemic by 2030. Therefore, it is crucial that young people’s perspectives are heard in the lead up to the conference, which is why we a consultation to help produce position papers reflecting young people’s voices is being launched.

Read More

World AIDS Day 2017 – message of Anke van Dam

Let us stand still on this World AIDS Day at all the brave people living with HIV that fight for their right to health. Let us think about those living in Eastern Europe and Central Asia (EECA), where only 28% of people with the diagnosis HIV have access to ARV treatment, and less than a quarter have a zero viral load. Where the majority of people at a higher risk for HIV face stigma and discrimination. Where the costs for some generic ARVs are higher than the patented ones. Where funds for prevention, treatment and care are diminishing with the years.

Read More